Rod Humerickhouse M.D., Asset Strategy Leader at ABBVIE discusses Phase 3 MURANO Trial At The 60th ASH Annual Meeting on Dec 1, 2018.
Phase 3 MURANO Trial
Rod Humerickhouse M.D., Asset Strategy Leader at ABBVIE discusses Phase 3 MURANO Trial At The 60th ASH Annual Meeting on Dec 1, 2018.